A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

10.1007/s11523-023-00997-z

Saved in:
Bibliographic Details
Main Authors: Razak, Albiruni R Abdul, Wang, Hung-Ming, Chang, Jang-Yang, Ahn, Myung-Ju, Munster, Pamela, Blumenschein Jr, George, Solomon, Benjamin, Lim, Darren Wan-Teck, Hong, Ruey-Long, Pfister, David, Saba, Nabil F, Lee, Se-Hoon, van Herpen, Carla, Quadt, Cornelia, Bootle, Douglas, Blumenstein, Lars, Demanse, David, Delord, Jean-Pierre
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Language:English
Published: SPRINGER 2024
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/248889
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-248889
record_format dspace
spelling sg-nus-scholar.10635-2488892024-11-11T21:42:39Z A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Razak, Albiruni R Abdul Wang, Hung-Ming Chang, Jang-Yang Ahn, Myung-Ju Munster, Pamela Blumenschein Jr, George Solomon, Benjamin Lim, Darren Wan-Teck Hong, Ruey-Long Pfister, David Saba, Nabil F Lee, Se-Hoon van Herpen, Carla Quadt, Cornelia Bootle, Douglas Blumenstein, Lars Demanse, David Delord, Jean-Pierre DUKE-NUS MEDICAL SCHOOL Assoc Prof Wan-Teck Darren Lim Science & Technology Life Sciences & Biomedicine Oncology PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR IRRADIATION PX-866 TRIAL MODEL 10.1007/s11523-023-00997-z TARGETED ONCOLOGY 18 6 853-868 2024-06-13T05:51:33Z 2024-06-13T05:51:33Z 2023-11 2024-06-12T12:25:17Z Article Razak, Albiruni R Abdul, Wang, Hung-Ming, Chang, Jang-Yang, Ahn, Myung-Ju, Munster, Pamela, Blumenschein Jr, George, Solomon, Benjamin, Lim, Darren Wan-Teck, Hong, Ruey-Long, Pfister, David, Saba, Nabil F, Lee, Se-Hoon, van Herpen, Carla, Quadt, Cornelia, Bootle, Douglas, Blumenstein, Lars, Demanse, David, Delord, Jean-Pierre (2023-11). A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. TARGETED ONCOLOGY 18 (6) : 853-868. ScholarBank@NUS Repository. https://doi.org/10.1007/s11523-023-00997-z 1776-2596 1776-260X https://scholarbank.nus.edu.sg/handle/10635/248889 en SPRINGER Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
IRRADIATION
PX-866
TRIAL
MODEL
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
IRRADIATION
PX-866
TRIAL
MODEL
Razak, Albiruni R Abdul
Wang, Hung-Ming
Chang, Jang-Yang
Ahn, Myung-Ju
Munster, Pamela
Blumenschein Jr, George
Solomon, Benjamin
Lim, Darren Wan-Teck
Hong, Ruey-Long
Pfister, David
Saba, Nabil F
Lee, Se-Hoon
van Herpen, Carla
Quadt, Cornelia
Bootle, Douglas
Blumenstein, Lars
Demanse, David
Delord, Jean-Pierre
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
description 10.1007/s11523-023-00997-z
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Razak, Albiruni R Abdul
Wang, Hung-Ming
Chang, Jang-Yang
Ahn, Myung-Ju
Munster, Pamela
Blumenschein Jr, George
Solomon, Benjamin
Lim, Darren Wan-Teck
Hong, Ruey-Long
Pfister, David
Saba, Nabil F
Lee, Se-Hoon
van Herpen, Carla
Quadt, Cornelia
Bootle, Douglas
Blumenstein, Lars
Demanse, David
Delord, Jean-Pierre
format Article
author Razak, Albiruni R Abdul
Wang, Hung-Ming
Chang, Jang-Yang
Ahn, Myung-Ju
Munster, Pamela
Blumenschein Jr, George
Solomon, Benjamin
Lim, Darren Wan-Teck
Hong, Ruey-Long
Pfister, David
Saba, Nabil F
Lee, Se-Hoon
van Herpen, Carla
Quadt, Cornelia
Bootle, Douglas
Blumenstein, Lars
Demanse, David
Delord, Jean-Pierre
author_sort Razak, Albiruni R Abdul
title A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
title_short A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
title_full A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
title_fullStr A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
title_full_unstemmed A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
title_sort phase 1b/2 study of alpelisib in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
publisher SPRINGER
publishDate 2024
url https://scholarbank.nus.edu.sg/handle/10635/248889
_version_ 1821208041672933376